Early Access — free while we kick the tires
EdgarHawk

Audet Juliette Berangere

Chief Business Officer

Officer
1 filing analyzed · 1 company · Latest 2024-09-30

Companies

Company Buys Sells Direction
NewAmsterdam Pharma Co N.V. NAMS 1 0 Net buying

Activity

September 2024
medium
Buy
1,104 shares
$17,333
Significance 4/10

NAMS Chief Business Officer buys 1,104 shares at $15.70; stock down -86.3% in annual revenue.

Audet Juliette Berangere, Chief Business Officer, purchased 1,104 shares at $15.70 on 2024-09-26 in her first recorded transaction in this company. The purchase of $17,332.80 occurs in the context of significant company stress: the company reported a net loss of $-39,007,000.00 in its most recent fiscal period, annual revenue declined -86.3%, and the stock is trading at $16.60, down -31.5% from its 52-week high of $24.23. The buy represents new insider ownership and stands out against a backdrop of severe revenue contraction and persistent losses, though the modest share count and recent entry position limit what can be inferred about insider conviction at this stage.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access